The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
Open accessAbstract
This minireview touches upon the challenges and opportunities peptides experience on the track to become an approved pharmaceutical. Peptide attributes originally considered troublesome with respect to drug development may now turn out to be more convenient rather than unfavourable. Besides characteristic high target affinity, biological peptides often exhibit higher than expected stability. Clearly natural selective pressure has optimised these biomolecules beyond what can be anticipated solely on the basis of their chemical nature. This concept is gradually finding its way into the pharma and biotech industry, as illustrated by a rise in medicinal peptide patent applications and developmental work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
Li, J. W.-H., & Vederas, J. C. (2009) · Science · doi:10.1126/science.1168243 · Cited by 2,052
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Expanding the Genetic Code of Escherichia coli
Wang, L., Brock, A., Herberich, B., & Schultz, P. G. (2001) · Science · doi:10.1126/science.1060077 · Cited by 1,499
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., & Cuervo, J. H. (1991) · Nature · doi:10.1038/354084a0 · Cited by 1,326
McDonnell, L. A., & Heeren, R. M. A. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20124 · Cited by 1,082
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Therapeutic potential of venom peptides
Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Miljanich, G. P. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043363884 · Cited by 607
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Hoofnagle, A. N., & Wener, M. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.003 · Cited by 561
Antimicrobial peptides stage a comeback
Fox, J. L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2572 · Cited by 524
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
Chen, M.-C., Sonaje, K., Chen, K.-J., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.087 · Cited by 420
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Therapeutic application of peptides and proteins: parenteral forever?
Antosova, Z., Mackova, M., Kral, V., & Macek, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.009 · Cited by 324
Nanoparticles for nasal vaccination
Csaba, N., Garcia-Fuentes, M., & Alonso, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.005 · Cited by 277
Site-specific incorporation of an unnatural amino acid into proteins in mammalian cells
Sakamoto, K. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf589 · Cited by 275
Prideaux, B., Dartois, V., Staab, D., Weiner, D. M., Goh, A., Via, L. E., Barry, C. E., & Stoeckli, M. (2011) · Analytical Chemistry · doi:10.1021/ac1029049 · Cited by 260
Chitosan-Alginate Blended Nanoparticles as Carriers for the Transmucosal Delivery of Macromolecules
Goycoolea, F. M., Lollo, G., Remuñán-López, C., Quaglia, F., & Alonso, M. J. (2009) · Biomacromolecules · doi:10.1021/bm9001377 · Cited by 238
Vandamme (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1045 · Cited by 238
Anti-infection Peptidomics of Amphibian Skin
Li, J., Xu, X., Xu, C., Zhou, W., Zhang, K., Yu, H., Zhang, Y., Zheng, Y., Rees, H. H., Lai, R., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600334-mcp200 · Cited by 224
Venomics: a new paradigm for natural products-based drug discovery
Vetter, I., Davis, J. L., Rash, L. D., Anangi, R., Mobli, M., Alewood, P. F., Lewis, R. J., & King, G. F. (2011) · Amino Acids · doi:10.1007/s00726-010-0516-4 · Cited by 197
Large-scale synthesis of peptides
Andersson, L. I., Blomberg, L., Flegel, M., Lepša, L., Nilsson, B., & Verlander, M. S. (2000) · Biopolymers · Cited by 196
Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection
TENNESSEN, J. A. (2005) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2005.00925.x · Cited by 192
Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
Sharma, S., Mukkur, T. K. S., Benson, H. A. E., & Chen, Y. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21493 · Cited by 160
Recent advances in nanocarrier-based mucosal delivery of biomolecules
Kammona, O., & Kiparissides, C. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.040 · Cited by 142
Classes and Prediction of Cell-Penetrating Peptides
Lindgren, M., & Langel, Ü. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_1 · Cited by 133
Next-generation peptide vaccines for advanced cancer
Yamada, A., Sasada, T., Noguchi, M., & Itoh, K. (2013) · Cancer Science · doi:10.1111/cas.12050 · Cited by 124
Riemer, A. B., Klinger, M., Wagner, S. N., Bernhaus, A., Mazzucchelli, L., Pehamberger, H., Scheiner, O., Zielinski, C. C., & Jensen‐Jarolim, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.394 · Cited by 97
Exenatide (Byetta) as a Novel Treatment Option for Type 2 Diabetes Mellitus
Bond, A. (2006) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2006.11928181 · Cited by 91
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
Noguchi, M., Sasada, T., & Itoh, K. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1379-1 · Cited by 91
Bioactive Peptides from Libraries
Falciani, C., Lozzi, L., Pini, A., & Bracci, L. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.02.009 · Cited by 89
Nanocarriers for Pulmonary Administration of Peptides and Therapeutic Proteins
Andrade, F., Videira, M., Ferreira, D., & Sarmento, B. F. C. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.143 · Cited by 78
Edwards, C. M. B. (1999) · QJM · doi:10.1093/qjmed/92.1.1 · Cited by 73
van Remoortere, A., Jones, E. A., Deelder, A. M., & McDonnell, L. A. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm098 · Cited by 61
The big and small of drug discovery
Moore, A. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor748 · Cited by 54
Recent Patents on Antimicrobial Peptides
Pathan, F. K., Venkata, D. A., & Panguluri, S. K. (2010) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221510790410831 · Cited by 25
Vancomycin resistance: are there better glycopeptides coming?
Linden, P. K. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.917 · Cited by 21
Rare-disease drugs boosted by new Prescription Drug User Fee Act
Fox, J. L. (2012) · Nature Biotechnology · doi:10.1038/nbt0812-733 · Cited by 14
Rendell, M. (2008) · Drug Development Research · doi:10.1002/ddr.20232 · Cited by 7
Cited by
Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Oller-Salvia, B., Sánchez-Navarro, M., Giralt, E., & Teixidó, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 442
Eskandari, S., Guerin, T., Toth, I., & Stephenson, R. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.013 · Cited by 381
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
Raheem, N., & Straus, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02866 · Cited by 369
Late‐Stage Peptide Diversification by Position‐Selective C−H Activation
Wang, W., Lorion, M. M., Shah, J., Kapdi, A. R., & Ackermann, L. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806250 · Cited by 335
Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
Erak, M., Bellmann-Sickert, K., Els-Heindl, S., & Beck-Sickinger, A. G. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.012 · Cited by 324
Metadata
- Authors
- Uhlig, T., Kyprianou, T., Martinelli, F. G., Oppici, C. A., Heiligers, D., Hills, D., Calvo, X. R., & Verhaert, P.
- Venue
- EuPA Open Proteomics
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 4
- Pages
- 58-69
- ISSN
- 2212-9685 (ISSN-L)
- OpenAlex
- W2034265369
- Cited by
- 456
- References
- 43
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.